These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31041385)

  • 21. Molecular Dynamics Reveals a DNA-Induced Dynamic Switch Triggering Activation of CRISPR-Cas12a.
    Saha A; Arantes PR; Hsu RV; Narkhede YB; Jinek M; Palermo G
    J Chem Inf Model; 2020 Dec; 60(12):6427-6437. PubMed ID: 33107304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striking Plasticity of CRISPR-Cas9 and Key Role of Non-target DNA, as Revealed by Molecular Simulations.
    Palermo G; Miao Y; Walker RC; Jinek M; McCammon JA
    ACS Cent Sci; 2016 Oct; 2(10):756-763. PubMed ID: 27800559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional insights into the
    Zuo Z; Zolekar A; Babu K; Lin VJ; Hayatshahi HS; Rajan R; Wang YC; Liu J
    Elife; 2019 Jul; 8():. PubMed ID: 31361218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for mismatch surveillance by CRISPR-Cas9.
    Bravo JPK; Liu MS; Hibshman GN; Dangerfield TL; Jung K; McCool RS; Johnson KA; Taylor DW
    Nature; 2022 Mar; 603(7900):343-347. PubMed ID: 35236982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
    Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
    Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA Unwinding Equilibrium Serves as a Checkpoint for CRISPR-Cas12a Target Discrimination.
    Singh J; Liu KG; Allen A; Jiang W; Qin PZ
    bioRxiv; 2023 May; ():. PubMed ID: 37292754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
    Singh J; Liu KG; Allen A; Jiang W; Qin PZ
    Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacing the
    Villiger L; Schmidheini L; Mathis N; Rothgangl T; Marquart K; Schwank G
    Mol Ther Nucleic Acids; 2021 Dec; 26():502-510. PubMed ID: 34631280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for Reduced Dynamics of Three Engineered HNH Endonuclease Lys-to-Ala Mutants for the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Associated 9 (CRISPR/Cas9) Enzyme.
    Wang J; Skeens E; Arantes PR; Maschietto F; Allen B; Kyro GW; Lisi GP; Palermo G; Batista VS
    Biochemistry; 2022 May; 61(9):785-794. PubMed ID: 35420793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9.
    Singh D; Sternberg SH; Fei J; Doudna JA; Ha T
    Nat Commun; 2016 Sep; 7():12778. PubMed ID: 27624851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for Cas9 off-target activity.
    Pacesa M; Lin CH; Cléry A; Saha A; Arantes PR; Bargsten K; Irby MJ; Allain FH; Palermo G; Cameron P; Donohoue PD; Jinek M
    Cell; 2022 Oct; 185(22):4067-4081.e21. PubMed ID: 36306733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Broad-Spectrum Inhibitor of CRISPR-Cas9.
    Harrington LB; Doxzen KW; Ma E; Liu JJ; Knott GJ; Edraki A; Garcia B; Amrani N; Chen JS; Cofsky JC; Kranzusch PJ; Sontheimer EJ; Davidson AR; Maxwell KL; Doudna JA
    Cell; 2017 Sep; 170(6):1224-1233.e15. PubMed ID: 28844692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-Specific Labeling Reveals Cas9 Induces Partial Unwinding Without RNA/DNA Pairing in Sequences Distal to the PAM.
    Li Y; Liu Y; Singh J; Tangprasertchai NS; Trivedi R; Fang Y; Qin PZ
    CRISPR J; 2022 Apr; 5(2):341-352. PubMed ID: 35352981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
    Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
    Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalytic Mechanism of Non-Target DNA Cleavage in CRISPR-Cas9 Revealed by
    Casalino L; Nierzwicki Ł; Jinek M; Palermo G
    ACS Catal; 2020 Nov; 10(22):13596-13605. PubMed ID: 33520346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single molecule methods for studying CRISPR Cas9-induced DNA unwinding.
    Okafor IC; Choi J; Ha T
    Methods; 2022 Aug; 204():319-326. PubMed ID: 34767923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of target DNA cleavage and the role of Mg2+ in the catalysis of CRISPR-Cas9.
    Nierzwicki Ł; East KW; Binz JM; Hsu RV; Ahsan M; Arantes PR; Skeens E; Pacesa M; Jinek M; Lisi GP; Palermo G
    Nat Catal; 2022 Oct; 5(10):912-922. PubMed ID: 36778082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.